Less than five per cent of adults with overactive bladder currently treated with drug therapies:… EP News Bureau Jan 6, 2022 The company noted that despite this surprisingly low number and the clear need for new therapies, the late-stage pipeline is…
Treatment for a form of bladder dysfunction in pediatric patients approved by the US FDA EP News Bureau May 27, 2020 The efficacy of VESIcare LS for the treatment of neurogenic detrusor overactivity (NDO) was established in two clinical trials…
Strides Pharma Science arm gets US FDA nod for drug to treat overactive bladder Press Trust of India Sep 27, 2019 The approved product is a generic version of Vesicare tablets of Astellas Pharma US
